O	O	O	0	1	T	T	B-NP	NN	B-cell_type	3	NMOD	B-cell_type
O	O	O	1	2	-	-	I-NP	HYPH	I-cell_type	3	NMOD	I-cell_type
O	O	O	2	13	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	10	SUB	I-cell_type
O	O	O	14	18	from	from	B-PP	IN	O	3	NMOD	O
O	O	O	19	30	individuals	individual	B-NP	NNS	O	4	PMOD	O
O	O	O	31	35	with	with	B-PP	IN	O	5	NMOD	O
O	O	O	36	44	filarial	filarial	B-NP	JJ	O	8	AMOD	O
O	O	O	45	57	inflammatory	inflammatory	I-NP	JJ	O	9	NMOD	O
O	O	O	58	65	disease	disease	I-NP	NN	O	6	PMOD	O
O	O	O	66	70	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	71	80	increased	increase	I-VP	VBN	O	10	VC	O
O	O	O	81	97	transendothelial	transendothelial	B-NP	JJ	O	13	NMOD	O
O	O	O	98	107	migration	migration	I-NP	NN	O	11	OBJ	O
O	O	O	108	110	in	in	B-ADVP	FW	O	13	NMOD	O
O	O	O	111	116	vitro	vitro	I-ADVP	FW	O	14	AMOD	O
O	O	O	116	117	.	.	O	.	O	10	P	O

O	O	O	119	122	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	123	125	in	in	I-NP	FW	O	3	AMOD	O
O	O	O	126	131	vitro	vitro	I-NP	FW	O	5	NMOD	O
O	O	O	132	148	transendothelial	transendothelial	I-NP	JJ	O	5	NMOD	O
O	O	O	149	158	migration	migration	I-NP	NN	O	15	SUB	O
O	O	O	159	161	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	162	173	circulating	circulate	B-VP	VBG	B-cell_type	14	NMOD	B-cell_type
O	O	O	174	182	filarial	filarial	B-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	183	190	antigen	antigen	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	190	191	-	-	B-NP	HYPH	I-cell_type	14	NMOD	I-cell_type
O	O	O	191	199	specific	specific	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	200	201	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	201	202	-	-	I-NP	HYPH	I-cell_type	14	NMOD	I-cell_type
O	O	O	202	207	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	208	211	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	212	220	examined	examine	I-VP	VBN	O	15	VC	O
O	O	O	221	223	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	224	234	Wuchereria	Wuchereria	B-NP	NNP	O	20	NMOD	O
O	O	O	235	244	banerofti	banerofti	I-NP	NN	O	20	NMOD	O
O	O	O	245	254	infection	infection	I-NP	NN	O	17	PMOD	O
O	O	O	254	255	.	.	O	.	O	15	P	O

O	O	O	256	267	Circulating	Circulate	B-NP	VBG	B-cell_type	4	NMOD	B-cell_type
O	O	O	268	269	T	T	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	O	269	270	-	-	I-NP	HYPH	I-cell_type	4	NMOD	I-cell_type
O	O	O	270	275	cells	cell	I-NP	NNS	I-cell_type	16	SUB	I-cell_type
O	O	O	276	280	from	from	B-PP	IN	O	4	NMOD	O
O	O	O	281	292	individuals	individual	B-NP	NNS	O	5	PMOD	O
O	O	O	293	297	with	with	B-PP	IN	O	6	NMOD	O
O	O	O	298	305	filaria	filaria	B-NP	NN	O	7	PMOD	O
O	O	O	305	306	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	306	313	induced	induce	I-NP	VBN	O	9	NMOD	O
O	O	O	314	323	lymphatic	lymphatic	I-NP	JJ	O	12	NMOD	O
O	O	O	324	333	pathology	pathology	I-NP	NN	O	10	VMOD	O
O	O	O	334	335	(	(	O	(	O	15	DEP	O
O	O	O	335	337	LP	LP	B-NP	NN	O	15	DEP	O
O	O	O	337	338	)	)	O	)	O	12	NMOD	O
O	O	O	339	342	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	343	356	significantly	significantly	B-NP	RB	O	18	AMOD	O
O	O	O	357	364	greater	great	I-NP	JJR	O	19	NMOD	O
O	O	O	365	374	migration	migration	I-NP	NN	O	16	OBJ	O
O	O	O	375	382	through	through	B-PP	IN	O	19	NMOD	O
O	O	O	383	395	unstimulated	unstimulated	B-NP	JJ	O	20	PMOD	O
O	O	O	396	401	HUVEC	HUVEC	I-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	O	402	412	monolayers	monolayer	I-NP	NNS	I-cell_type	21	NMOD	I-cell_type
O	O	O	413	417	than	than	B-SBAR	IN	O	16	VMOD	O
O	O	O	418	421	did	do	O	VBD	O	24	DEP	O
O	O	O	422	423	T	T	B-NP	NN	B-cell_type	28	NMOD	B-cell_type
O	O	O	423	424	-	-	O	HYPH	I-cell_type	28	NMOD	I-cell_type
O	O	O	424	429	cells	cell	B-NP	NNS	I-cell_type	25	SUB	I-cell_type
O	O	O	430	434	from	from	B-PP	IN	O	28	NMOD	O
O	O	O	435	447	asymptomatic	asymptomatic	B-NP	JJ	O	31	AMOD	O
O	O	O	448	456	infected	infected	I-NP	JJ	O	35	NMOD	O
O	O	O	457	458	(	(	O	(	O	34	DEP	O
O	O	O	458	460	MF	MF	B-ADJP	JJ	O	34	DEP	O
O	O	O	460	461	)	)	O	)	O	31	AMOD	O
O	O	O	462	473	individuals	individual	B-NP	NNS	O	29	PMOD	O
O	O	O	474	475	(	(	O	(	O	42	DEP	O
O	O	O	475	476	P	P	B-NP	NN	O	41	SUB	O
O	O	O	477	478	=	=	B-VP	SYM	O	41	VMOD	O
O	O	O	479	480	0	0	B-NP	CD	O	41	AMOD	O
O	O	O	480	481	.	.	I-NP	SYM	O	41	AMOD	O
O	O	O	481	483	04	04	I-NP	CD	O	42	DEP	O
O	O	O	483	484	)	)	O	)	O	28	NMOD	O
O	O	O	484	485	.	.	O	.	O	16	P	O

O	O	O	486	488	In	In	B-PP	IN	O	28	VMOD	O
O	O	O	489	497	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	498	500	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	501	504	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	505	507	MF	MF	I-NP	NN	O	6	NMOD	O
O	O	O	508	519	individuals	individual	I-NP	NNS	O	3	PMOD	O
O	O	O	520	525	where	where	B-ADVP	WRB	O	6	NMOD	O
O	O	O	526	528	no	no	B-NP	DT	O	9	NMOD	O
O	O	O	529	535	effect	effect	I-NP	NN	O	10	SUB	O
O	O	O	536	539	was	be	B-VP	VBD	O	7	SBAR	O
O	O	O	540	544	seen	see	I-VP	VBN	O	10	VC	O
O	O	O	544	545	,	,	O	,	O	28	P	O
O	O	O	546	562	transendothelial	transendothelial	B-NP	JJ	O	14	NMOD	O
O	O	O	563	572	migration	migration	I-NP	NN	O	28	SUB	O
O	O	O	573	575	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	576	578	48	48	B-NP	CD	O	21	AMOD	O
O	O	O	578	579	-	-	I-NP	HYPH	O	21	P	O
O	O	O	579	581	hr	hr	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	582	590	filarial	filarial	I-NP	JJ	I-protein	20	NMOD	I-protein
O	O	O	591	598	antigen	antigen	I-NP	NN	I-protein	21	AMOD	I-protein
O	O	O	599	609	stimulated	stimulate	I-NP	VBD	O	24	NMOD	O
O	O	O	610	611	T	T	I-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	O	611	612	-	-	I-NP	HYPH	I-cell_type	24	NMOD	I-cell_type
O	O	O	612	617	cells	cell	B-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	618	622	from	from	B-PP	IN	O	24	NMOD	O
O	O	O	623	625	LP	LP	B-NP	NN	O	27	NMOD	O
O	O	O	626	637	individuals	individual	I-NP	NNS	O	25	PMOD	O
O	O	O	638	641	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	642	655	significantly	significantly	B-ADVP	RB	O	28	PRD	O
O	O	O	656	657	(	(	O	(	O	36	DEP	O
O	O	O	657	658	P	P	B-NP	NN	O	35	SUB	O
O	O	O	659	660	=	=	B-VP	SYM	O	35	VMOD	O
O	O	O	661	662	0	0	B-NP	CD	O	35	NMOD	O
O	O	O	662	663	.	.	I-NP	SYM	O	35	NMOD	O
O	O	O	663	665	01	01	I-NP	CD	O	36	DEP	O
O	O	O	665	666	)	)	O	)	O	29	AMOD	O
O	O	O	667	674	greater	great	B-ADJP	JJR	O	29	AMOD	O
O	O	O	675	679	than	than	B-PP	IN	O	29	AMOD	O
O	O	O	680	689	migration	migration	B-NP	NN	O	49	NMOD	O
O	O	O	690	692	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	693	695	48	48	B-NP	CD	O	44	NMOD	O
O	O	O	695	696	-	-	I-NP	HYPH	O	44	P	O
O	O	O	696	698	hr	hr	I-NP	NN	O	44	NMOD	O
O	O	O	699	704	media	medium	I-NP	NNS	O	40	PMOD	O
O	O	O	704	705	-	-	O	HYPH	O	49	P	O
O	O	O	705	715	stimulated	stimulate	B-NP	VBN	B-cell_type	49	NMOD	B-cell_type
O	O	O	716	717	T	T	I-NP	NN	I-cell_type	49	NMOD	I-cell_type
O	O	O	717	718	-	-	I-NP	HYPH	I-cell_type	49	NMOD	I-cell_type
O	O	O	718	723	cells	cell	I-NP	NNS	I-cell_type	38	PMOD	I-cell_type
O	O	O	723	724	.	.	O	.	O	28	P	O

O	O	O	725	727	In	In	B-PP	IN	O	19	VMOD	O
O	O	O	728	731	six	six	B-NP	CD	O	1	PMOD	O
O	O	O	732	734	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	735	740	seven	seven	B-NP	CD	O	5	NMOD	O
O	O	O	741	749	patients	patient	I-NP	NNS	O	3	PMOD	O
O	O	O	750	758	examined	examine	B-VP	VBN	O	5	NMOD	O
O	O	O	758	759	,	,	O	,	O	19	P	O
O	O	O	760	770	inhibition	inhibition	B-NP	NN	O	19	SUB	O
O	O	O	771	773	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	774	777	the	the	B-NP	DT	O	18	NMOD	O
T1	B-Protein	B-Protein	778	781	VLA	VLA	I-NP	NN	B-protein	18	NMOD	B-protein
T1	I-Protein	I-Protein	781	782	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T1	I-Protein	I-Protein	782	783	4	4	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	O	783	784	/	/	I-NP	SYM	O	18	NMOD	O
T2	B-Protein	B-Protein	784	788	VCAM	VCAM	I-NP	NN	B-protein	18	NMOD	B-protein
T2	I-Protein	I-Protein	788	789	-	-	B-NP	HYPH	O	18	NMOD	O
T2	I-Protein	I-Protein	789	790	1	1	I-NP	CD	O	18	NMOD	O
O	O	O	791	798	pathway	pathway	I-NP	NN	O	9	PMOD	O
O	O	O	799	807	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	808	810	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	811	818	greater	great	B-NP	JJR	O	22	AMOD	O
O	O	O	819	823	than	than	I-NP	IN	O	25	NMOD	O
O	O	O	824	826	50	50	I-NP	CD	O	22	AMOD	O
O	O	O	826	827	%	%	I-NP	NN	O	22	AMOD	O
O	O	O	828	838	inhibition	inhibition	I-NP	NN	O	20	PMOD	O
O	O	O	839	841	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	842	858	transendothelial	transendothelial	B-NP	JJ	O	28	NMOD	O
O	O	O	859	868	migration	migration	I-NP	NN	O	26	PMOD	O
O	O	O	869	871	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	872	873	T	T	B-NP	NN	B-cell_type	32	NMOD	B-cell_type
O	O	O	873	874	-	-	O	HYPH	I-cell_type	32	NMOD	I-cell_type
O	O	O	874	879	cells	cell	B-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	879	880	.	.	O	.	O	19	P	O
